from which the Russians quickly prepared some ten million doses. By the fall of 1959, millions of children in the Soviet Republics had received the Sabin vaccine.
Strongly positive results in terms of safety and effectiveness of the oral vaccine were reported by the Russian scientists at the First International Conference on Live Poliovirus Vaccines, held in Washington, DC, at the Pan American branch of WHO in June 1959 [2, 3] . The findings stimulated great interest and lively discussion at the meeting, but in the United States there was some skepticism concerning reliability of the data, particularly in relation to surveillance of vaccinees and their contacts, a necessity for assuring vaccine safety. The fear concerned the stability of the live attenuated virus. In the course of multiplication in the intestinal tract, some mutation was known to occur. The frequency of contact infections raised the possibility that serial passage might ultimately result in emergence of neurovirulent virus strains. Although the Russian investigators had reported no significant changes in pathogenicity for monkeys after ten human passages [3] , there was still some unease about the problem.
It was at this point (August 1959 ) that I was asked by WHO to visit the USSR, Czechoslovakia, and Poland to engage in a detailed evaluation of the quality of work in the laboratories involved, the care with which vaccinees were followed, and the standards employed to assure the vaccine's safety. After a six-week investigation of these aspects in several Soviet Republics, Czechoslovakia, and Poland, a detailed analysis was submitted to WHO. While this report was not published, it was distributed widely. Its positive assessment contributed to a rebirth of interest in the oral vaccine and paved the way for large field trials in the United States, leading to licensure of oral vaccine in 1961-62. Because of the importance of this 124-page report, and because of Arthur Viseltear's interest in the background of policy decisions concerning preventive programs, as illustrated in his work on swine influenza [4] , a precis of the findings in several USSR Republics appears in this paper. It is presented in the present tense, as it was written, recording observations made in the fall of 1959. As one can deduce from the report, the extraordinary massive immunization programs developed in the various Republics were possible because of the strengths of the then-existing sociopolitical organizations of the USSR.
ITINERARY AND AIMS
The period between August 30 and October 11 was spent in the Soviet Union, largely in Moscow, with visits to other areas, including Leningrad, Tashkent, and Riga. An attempt was made to review and evaluate the following features in connection with vaccination programs in the different areas:
1. In connection with the live virus vaccine programs, much discussion centered around methods employed in the collection, storing, shipping, and testing of various materials. The methods in all these areas were standard, with the usual minor variations which occur from one laboratory to the next. Stool specimens were employed for virus isolations rather than rectal swabs. All specimens collected in Estonia were taken or sent to a central poliomyelitis laboratory in the Microbiology Institute in Tallinn, where they were made into 20 percent suspensions and frozen. Some specimens (a few hundred) were tested in this local laboratory, but the majority-several thousands-were shipped to Moscow by air. During the winter, it was not necessary to ice the shipments, but, beginning in April, all were packed in dry ice for the trip. In Moscow, the work was carried out at Sokolinaya Gora under the direction of Dr vaccinating chiefly persons under 15 years. As of October 1959, part, or almost the entire designated age group of the population within most of the Republics, had been vaccinated. The total number of vaccinees was approximately 10,000,000, as indicated in Table 1 . Planning for vaccination was greatly facilitated by the availability of accurate population data obtained in January 1959, when a census of the entire country was carried out. Although age-specific statistics are not yet complete, information on total child population is known, and more complete information was expected to be available by the end of 1959.
Conduct of Vaccination
A preliminary propaganda campaign is carried out immediately before beginning a vaccination program. To many areas, Dr. Chumakov himself goes with one or more of his staff members. He addresses first the assembled physicians of the area, explaining the program, the organization, the role of the physicians, their responsibilities, both during the actual vaccination period and, subsequently, the importance of close surveillance, and so on. At the same time, there are radio and television broadcasts (by Dr. Chumakov) explaining to the people the necessity for their full cooperation if the program is to be successful. Newspapers and billboards carry notices of where and when vaccine will be distributed.
The organization for vaccine distribution varies slightly, depending on the nature of the area, but the principles are the same. In Estonia, for instance, a main town in each region of the Republic was selected, a town in which there was a laboratory with adequate refrigeration facilities. From these centers, teams went out daily, carrying the vaccine in iced thermos jugs. For rural distribution, teams, usually of three persons-two nurses and a "feldtscher" or assistant physician-went out to cover an assigned area. In towns, teams were set up in schools, nurseries, kindergartens, outpatient clinics, factories, and the like. A physician (vrach) supervised the activities of several teams. Preliminary lists of vaccinees had been prepared, and data on every vaccinated person was recorded. In the field, the data were usually in the form of a list, giving name, address, age, type of vaccine administered, and date of vaccination. This information was then collected by the physician and referred to the local sanitary-epidemiological station, from whence it travelled to the regional sanitaryepidemiological station. The data were also transferred to the card kept by each local pediatrician on every child in his district.
Selection of Vaccinees
Since the program was set up as an effort at mass vaccination, there was no selection of vaccinees, nor were there any selected control groups. This organization was deliberate, based first on humanitarian principles, the desire to eliminate paralytic poliomyelitis completely, and, second, on the idea that spread of the attenuated strains would destroy the validity of the control group by involuntary vaccination of an unknown number of contacts. There is therefore no claim by Dr. Chumakov that a controlled trial has been carried out, but rather that a mass program has been put into effect. As in any mass program, however, a certain number of persons living in designated areas were missed, either due to absence, illness, or reluctance to take part.
Vaccine Administration Schedules
The plan of vaccination has varied slightly in different Republics. Serial administration, starting with Type I, then Type III, then Type II, at monthly intervals was used in the beginning; the populations in Lithuania and Estonia were vaccinated in this manner. In Lithuania, a comparison was made between those vaccinated serially with the three types given in different order, and with groups receiving a triple vaccine, given either once or repeated after one month. The serologic tests to be carried out on the vaccinees are as yet incomplete, but preliminary data based in part on studies of nursery populations indicated no significant difference in the end result if the conventional 1-111-I scheme was used, or if a trivalent vaccine was given. In many Republics, therefore, trivalent vaccine was used, and, by October 1959, some 5,000,000 children had received this form. Preliminary results with candy vaccine given to small groups of nursery children indicated that infection and serological responses were satisfactory. Most recent communications from Dr. Chumakov, however, indicate that the current plan for vaccinating the entire country will call for four doses of vaccine: three of the monovalent, Type I, Type III, and Type II at fourto six-week intervals, followed by one dose of trivalent vaccine after an interval of three to 18 months.
Pre-Vaccinal Immune Status ofthe Population
In all areas where the live poliovirus vaccine programs were carried out, serological surveys of varying size were made, but in most instances they do not represent a random sampling because, for the younger age groups, too much reliance seems to have been placed on so-called "organized children," i.e., children aged 0-3 years living in nurseries. These children are orphans or have been placed in such institutions because their parents are away or unable to take care of them for one reason or another. Another group heavily represented is a day nursery group of children (aged eight months to three years) who are deposited by their mothers at the nursery each morning at 8 A.M. and collected at 4 P.M. Children attending such institutions represent about 15 percent of the population, aged six months to three years. These two groups make up 100 percent of the 0-3-year age group surveyed, but obviously are not representative of the population at large. The age group four to seven was also drawn from institutionalized children to a great extent and from kindergartens. School children account for the age groups seven to 14, and factory workers largely for the adults. Blood specimens are usually collected by nurses, specially trained, but in some instances by physicians. Ordinary syringes are used, and 3-5 ml taken from antecubital or scalp veins and occasionally from neck veins. Surveillance Follow-up to identify poliomyelitis cases, particularly those which might develop in vaccinated children, seems to be very good. As an infectious disease, it has a priority, and, following the propaganda associated with the live virus vaccine program, it has particular prominence. In each area, the teams responsible for vaccination were also concerned with surveillance. In Tashkent, where vaccine was administered beginning on July 19, during an epidemic, each home was visited every five to six days until mid-September, in order to check on possible cases. In general, however, the pediatrician responsible for the area is the one who sees the sick child, makes a diagnosis, and notifies the local sanitary-epidemiological station of the case. An epidemiologist then visits the home of the child, fills out an elaborate epidemiological history chart, enquires about illness among contacts, sometimes collects specimens from those with suspicious illness, and the like.
The Ministry of Health in Moscow has set up a special notification system for poliomyelitis cases, which requires that the local physician notify by telephone or telegraph the regional sanitary-epidemiological station, which in turn telephones or telegraphs the central sanitary-epidemiological station of the Republic. There is no difficulty in establishing whether the child has been vaccinated or not, since this information is on file in the local pediatrician's records and also at the sanitaryepidemiological station. All suspicious cases, i.e., all cases with signs of acute infection of the central nervous system, are hospitalized; in remote areas, transportation to the hospital may be arranged by plane.
Reporting of Cases
A special-and complicated-form has been provided for the reporting of poliomyelitis cases. As in most reporting systems, there is some variation from place to place in the completeness and speed with which cases are notified. Under the USSR system, however, it would seem that all paralytic cases are seen and reported. It is probable that some mild cases of aseptic meningitis might slip through, but, in general, overreporting rather than underreporting seems to be the rule. The team of specialists which is sent to confirm the diagnosis not infrequently eliminates the case as "not poliomyelitis." Laboratory Confirmation of Cases
The collection of specimens from suspected poliomyelitis cases also varies somewhat, depending on the area. In Karaganda, Tashkent, Moscow city, the collections are good; though in Moscow region, for example, which is largely rural, delays and failures to collect specimens are problems. The routine is to collect at least two fecal specimens during the acute phase of illness and at least an acute and a convalescent blood specimen. Specimens are sent first to the local sanitary-epidemiological station, then to whatever laboratory has been designated for testing-a regional one, or the Moscow laboratories of Dr. Chumakov. In some areas, fecal specimens are divided, part being tested in the regional laboratories and part being sent to Moscow. Serological tests are performed largely in the Moscow laboratories, although, in a few areas, the regional laboratories also perform some of the tests. It is hard to visualize any state, particularly the larger ones in the United States, where the laboratory confirmation of the clinically diagnosed cases of poliomyelitis is so universally carried out.
EXAMPLES OF DIFFERENT VACCINATION PROGRAMS
Details on the conduct of vaccination and preliminary results were available for only some of the Republics at the time of my visit. These particulars are given in the following sections.
VACCINATION IN ESTONIA
Estonia has had one of the highest rates of poliomyelitis in the Soviet Union. The largest epidemic recorded occurred in 1958, when the attack rate reached 89 per 100,000. The age distribution was not unlike that of Sweden, with 20 to 30 percent of cases in adults over 20 years. Killed (Salk-type) vaccine has been used in the past few years on a modest scale by the Ministry of Health of the Republic; exact data on the percentage vaccinated in each age group were not available.
Serological Survey
In spite of the tremendous epidemic of 1958, a considerable number of susceptibles to one or more types of poliovirus remained in the population, as shown by data presented by Dr. Chumakov in June 1959 [2] . Of the 519 children and adults surveyed, the percentage lacking antibodies to all three types was close to 50 percent for children under ten; for the individual types, the figures were 44 percent, 25 percent, and 51 percent for Types I, II, and III, respectively. Such results indicate a large segment of susceptibles in this population.
Vaccination Program
Estonia was the first Republic in which Dr. Chumakov and his team undertook a mass vaccination. By May 10, 1959, a total of 657,000 of the population of 1.1 million had been vaccinated, including about 60-70 percent of the children up to age 15, and 50 percent of those 16-50 years. Vaccination continued throughout the summer of 1959, chiefly among the youngest children, so that the total number of vaccinees by September 1 was approximately 716,000. The schedule used was Type I, followed at monthly intervals by Type III, and Type II. Coincidentally an extensive program was set up for following virus excretion and serological conversion in vaccinees and their contacts in a number of groups, including children in nurseries, school children, and young adult students. In all, some 10,000 fecal specimens and several thousand bloods were collected. Dr. Drosdov, Dr. Shirman, and two technicians went from the Moscow Institute for Poliomyelitis Research to the Laboratory in Tallinn, where they remained for several months, through the vaccination period. The bulk of the specimens are now being tested in Moscow.
Clinical Surveillance
In Estonia, a center for the Republic was established for this purpose in Tartu, under the direction of Professor Randam, who has had many years of experience with poliomyelitis. In addition, a special epidemiological bureau was organized to survey all poliomyelitis cases, suspected cases, and contacts. An effort was made to obtain three fecal specimens during the acute phase, and two to three acute and convalescent blood specimens. Laboratory tests are currently under way.
Effect of the Vaccination Program
The vaccination campaign completed in May was followed by a reduction in the number of cases and, most striking, absence of the usual summer rise. Furthermore, there was no suggestion on clinical or epidemiological evidence that the vaccine virus in spreading among susceptible contacts had acquired enhanced virulence after multiple passages. 
History ofPoliomyelitis in the Area
Uzbekistan has had one of the lowest poliomyelitis attack rates of any Republic. Only sporadic cases in young children have been notified in the past, but, as in neighboring Kazakhstan, there has been a gradual increase in their number in the past decade. Beginning in June 1959, the first epidemic appeared. It centered in Tashkent, but an increased incidence was noted throughout the Republic. As previously, the youngest age group was involved; 80 percent of cases were in children under four years. By mid-July, the number of cases was increasing rapidly; at this time, it was decided to try to check the epidemic by a rapid mass application of trivalent live poliovirus vaccine covering all children under 15 years of age. This program was begun on July 19, under the personal direction of Dr. Chumakov.
Organization ofthe Vaccination Program
Because of the emergency nature of the vaccination program in Tashkent, a vigorous propaganda campaign was carried on for several days via the television, radio, and press, with Dr. Chumakov playing a prominent role. The 2,000 physicians of the city, regardless of their specialties, were asked to assist. The city is divided into 23 districts, and the health station in each provided a list of children in its area.
July 19 was a Sunday. All families with children were urged, through media communications, to remain at home until visited by a vaccination team. Vaccine was given by ordinary medicine dropper in a spoon (provided by the family) with water; the oral dose was two drops, which amount had been calculated to contain approximately 100,000 TCD50 of each of the three types. The number of children vaccinated on July 19 was 182,000; on July 22-23, 122,000, and on August 12, 160,000. The total number of vaccinees was > 400,000, which represents almost the entire estimated population of Tashkent under 15 years, according to the January 1959 census. Although the vaccination was voluntary, considerable pressure was exerted in the course of television and radio propaganda, taking advantage of the fear experienced by all parents in the face of a poliomyelitis epidemic. The response was thus quite close to 100 percent. Approximately six weeks after initial vaccination, a second dose was given to virtually all who had received the first; the administration of the second dose covered a period of four days.
Collection and Testing ofSpecimens
Fecal specimens were collected from about 100 cases during the early part of the epidemic, before vaccination was carried out. Few of them had been tested by September 1959, but five strains of Type I, one of Type III, and a mixture of Types I and III had already been isolated. Several untypeable agents-possibly mixtureshad also been encountered. It would seem likely that in a population such as that of Tashkent, inapparent infections with various enteroviruses would be common in the youngest age group.
After vaccination, specimens were collected from all definite and suspected cases of poliomyelitis; throat swabs were taken from some, and fecal samples were obtained twice during the first week of admission. Acute and convalescent blood samples were also collected.
Laboratory studies, including virus isolations from fecal specimens and flies, and serological tests, are in progress in the newly established poliomyelitis unit at the Tashkent Serum and Vaccine Institute. Preliminary results indicate that Type I was active, but all isolates had not yet been typed. The extensive laboratory program planned is ambitious for a small unit; it will doubtless be some time before results are available, in spite of the constant advice and support of Dr. Chumakov's laboratory in Moscow.
Course ofthe Epidemic
A total of approximately 400 cases occurred, 80 percent of which were in children under four. Following vaccination, the epidemic fell off sharply. It was short, lasting only some two and a half months. This duration was in contrast to the experience of nearby Alma Ata, Kazakhstan, a city of similar size and type, where a first epidemic occurred in 1954 and lasted over a six-month period. The difference suggests that oral vaccine may have played a role in shortening the Tashkent epidemic. Furthermore, it is clear that mass vaccination of the child population in the middle of a summer outbreak did not increase the incidence of poliomyelitis. 
History ofPoliomyelitis in Latvia
Epidemic poliomyelitis in Latvia has followed a pattern similar to that in the nearby Scandinavian countries, with increasingly severe outbreaks. The population of the Republic is about 2,000,000, and of the capital city, Riga, 600,000. Attack rates have always been highest in the cities, particularly Riga. The most severe epidemic occurred in 1956, in which there were 528 cases, an attack rate of 88 per 100,000. During 1957, an extensive program using the Salk-type vaccine had been undertaken, and 82,000 children under 15 were given two doses followed by a third dose in 1958. In the city of Riga, virtually all children of this age group were so vaccinated; in the rest of the Republic, approximately 10-15 percent of the child population had received two or more doses. Although cases in older children and young adults continue to occur, there has been some shift recently toward a higher incidence in young children, i.e., under five years, particularly in the cities.
The Microbiology Institute in Riga
This institute, which operates under the auspices of The Latvian Academy of Medical Sciences, was constructed in the early 1930s. It consists of three or four small stucco laboratory and administrative buildings, three stories high, and a number of animal quarters. The laboratories are simple and well kept; there are many glasspartitioned working units. In the biochemistry and biophysics building, there is an electron microscope and, in addition, a variety of electronic equipment.
The Poliomyelitis Department was set up in 1956, at which time several of the senior staff spent some time in Moscow at the Institute for Poliomyelitis Research under Dr. Chumakov in order to obtain training in tissue culture and poliomyelitis work. The present staff consists of nine physicians and 15 technicians. The physicians are knowledgeable, young, conscientious, and enthusiastic. They look forward eagerly to continued work in the enterovirus field.
Laboratory Tests
Virus isolation is performed using human embryonic tissue, which is received twice weekly from abortions performed at the hospitals in Riga. In serologic tests, the methods employed are the same as those used in Moscow and other laboratories.
The Children's Hospital in Riga
This institution is an 800-bed hospital, probably about 25 years old, on the outskirts of the city. The deputy director, Dr. N. Pakalnin, is also the chief of the neuroinfection ward and has long been particularly interested in poliomyelitis. It is obvious that he has had great experience with the disease; he speaks English fluently and is thoroughly familiar with the clinical literature on poliomyelitis in English. The medical staff, in addition to Dr. Pakalnin, are experienced physicians, and the standards of medical and nursing care are high.
The Live Virus Vaccination Program in Latvia
The Republic is divided into 44 provinces, or regions; vaccine was administered in 21 of these, the other 23 being left as controls. In the past, the 21 vaccinated regions, which include the five cities, accounted for approximately 88 percent of the poliomyelitis cases, while in the control, non-vaccinated regions an average of only 12 percent of the total cases occurred.
During April and May 1959, approximately 413,000 individuals received monovalent Type I oral vaccine; one month later, 376,464 of these received Types II and III combined. The focus was primarily on children under 15 and on young adults; approximately 65 percent of these groups were vaccinated. As elsewhere, the regions to be vaccinated were divided, and teams consisting of one physician and two nurses covered a given population group. The vaccine was administered at polyclinics, nurseries, schools, and various special vaccine clinics. Each vaccinee was registered, and the records were forwarded to the Chief Epidemiologist in Riga.
Serological Surveys
A pre-vaccinal survey was carried out in seven selected regions in different parts of the Republic, exclusive of Riga. The sera were tested in Leningrad, in Dr. Smorodintsev's laboratory. Details of the results are not presently available, but Dr. Smorodintsev has reported that in Latvia "serological examination of selected groups of children of various ages prior to vaccination showed that 42 percent of them were negative to Type I, and about 40 percent to Types II 
SUMMARY: USSR
Extensive mass programs of poliomyelitis vaccination using Sabin's strains of virus have been carried out in the USSR, beginning in January 1959. To date, some 10-15,000,000 persons have been vaccinated. The evidence seems conclusive that these strains are safe, both to the vaccinees and to their communities. Surveillance of cases is good, and it seems very unlikely that paralytic cases of poliomyelitis would have been missed. The marked reduction of cases in 1959 in orally vaccinated Republics suggests that the vaccine may have played a significant role in reducing the incidence of paralytic poliomyelitis. Compared to the pattern of rising incidence in the past few years, and the five-year averages, the low incidence in 1959 stands out.
The standards of laboratory work in the areas evaluated are high. The facilities are adequate, and the laboratory personnel, both at the professional and technical levels, is extensive; however, there is often some delay in carrying out laboratory investigations of cases occurring in vaccinated areas. In view of the enormous amount of laboratory work to be completed in a year of many vaccination programs, it is understandable that final results are slow in coming. When completed, pre-and post-vaccinal serological surveys should aid greatly in estimating the effectiveness of the Sabin strains of attenuated live virus vaccine administered in various ways and under various epidemiological circumstances.
